Purchases and Sales Made in Q2 2023 in Lineage Cell Therapeutics, Inc. (LCTX)
This table provides information about the institutional ownership of Lineage Cell Therapeutics, Inc. (LCTX) during Q2 2023. The information is specifically focused on institutions that hold shares of Lineage Cell Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Sep 07, 2023
Q2 2023
|
St Germain D J CO Inc
Springfield, MA |
BUY
|
- |
2New |
$2.52 - $3.06
|
2
$1.12
|
|
|
Aug 10, 2023
Q2 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Aug 21, 2023
Q2 2023
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
SELL
|
- |
-5- 0.01% |
$6.3 - $7.65
|
46.8K
$26.2K
|
|
|
Jul 27, 2023
Q2 2023
|
Victory Capital Management Inc
|
SELL
|
- |
-428- 2.27% |
$539 - $655
|
18.4K
$10.3K
|
|
|
Aug 14, 2023
Q2 2023
|
Squarepoint Ops LLC
New York, NY |
SELL
|
- |
-931- 2.83% |
$1.17K - $1.42K
|
31.9K
$17.9K
|
|
|
Aug 14, 2023
Q2 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-1.99K- 19.98% |
$2.51K - $3.05K
|
7.98K
$4.47K
|
|
|
Aug 14, 2023
Q2 2023
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-3.76K- 4.22% |
$4.74K - $5.76K
|
85.3K
$47.8K
|
|
|
Aug 09, 2023
Q2 2023
|
Summit X, LLC
Chesterfield, MO |
SELL
|
- |
-7K- 31.93% |
$8.82K - $10.7K
|
14.9K
$8.36K
|
|
|
Jul 31, 2023
Q2 2023
|
Lpl Financial LLC
Fort Mill, SC |
SELL
|
- |
-14K- 10.8% |
$17.7K - $21.5K
|
116K
$65K
|
|
|
Aug 14, 2023
Q2 2023
|
High Tower Advisors, LLC
Chicago, IL |
SELL
|
- |
-16K- 31.93% |
$20.2K - $24.5K
|
34.1K
$19.1K
|
|
|
Aug 14, 2023
Q2 2023
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-17.5K- 26.08% |
$22.1K - $26.8K
|
49.6K
$27.8K
|
|
|
Jul 18, 2023
Q2 2023
|
Defender Capital, Llc.
|
SELL
|
- |
-26.4K- 0.51% |
$33.2K - $40.4K
|
5.11M
$2.86M
|
|
|
Aug 11, 2023
Q2 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-71.6K- 6.44% |
$90.2K - $110K
|
1.04M
$583K
|
|
|
Aug 14, 2023
Q2 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-154K- 50.27% |
$194K - $235K
|
152K
$85.2K
|
|
|
May 14, 2024
Q2 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-253K- 90.52% |
$319K - $387K
|
26.5K
$14.9K
|
|
|
Aug 14, 2023
Q2 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-253K- 90.52% |
$319K - $387K
|
26.5K
$14.9K
|
|
|
Aug 10, 2023
Q2 2023
|
Citigroup Inc
|
SELL
|
- |
-304K- 65.7% |
$383K - $465K
|
159K
$88.9K
|
|
|
Aug 14, 2023
Q2 2023
|
Laurion Capital Management LP
New York, NY |
SELL
|
- |
-412K- 17.31% |
$519K - $630K
|
1.97M
$1.1M
|
|
|
Aug 14, 2023
Q2 2023
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-573K- 96.07% |
$722K - $877K
|
23.4K
$13.1K
|
|
|
Aug 11, 2023
Q2 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-775K- 94.96% |
$977K - $1.19M
|
41.2K
$23.1K
|
|
|
Aug 14, 2023
Q2 2023
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-1.37M- 95.0% |
$1.73M - $2.1M
|
72.2K
$40.4K
|